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   This figure is included on page 3  
 of the print copy of the thesis held in  
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  This figure is included on page 4  
of the print copy of the thesis held in  
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1.4.2  APC Mutations in CRC 
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1.5  CRC statistics and therapy 
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1.7.2  The Effects of Inflammatory Bowel Disease and Benign Tumours 







































1.8  Current detection methods for CRC 
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1.9 Better  therapy 
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1.9.2 Targeted  therapies 
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1.11 Aims  
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2.4 Specimen  collection 
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2.5  Laser microdissection (LMD) 
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2.6  2D Difference gel electrophoresis (2D DIGE) 























































2.7 2  DE 
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2.7.2 Isoelectric  focusing 
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2.9 LC  MS/MS 













































































2.10 CK8 Phosphopeptide enrichment and MALDI TOF/TOF 
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2.11 1DE and western blotting  
































































































































































2.12.3 Staining  procedure 

































2.13 Real-time RT-PCR 
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2.13.4  Real-time PCR  
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3.2  Materials and methods 
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3.3.3  Identification of proteins increased in abundance in colorectal 
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3.4.3  Proteins identified as significantly increased in abundance in tumour 
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3.4.4  Proteins identified as significantly increased in abundance in tumour 
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4.2  Materials and methods 






















4.2.2   Immunofluorescence on frozen tissue  

























4.2.2.2  Desmin and Vimentin IF 
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4.3 Results 
4.3.1   Characterisation of the desmin antibody 
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4.4.9  The origin of tumour associated fibroblasts 
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5   Cytokeratin 8 Phosphorylation in CRC  
5.1 Introduction 
5.1.1  Cytokeratin 8 and CRC 
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Individual Tumour-Normal Abundance Ratios
Spot ID Ave.  Ratio
a P
b 1 2 34567 8
1 CK8 4.56 0.0003 2.50 8.70 3.50 6.20 5.20 5.10 1.30 3.90
2 CK8 4.36 0.0052 1.30 7.50 4.30 7.50 3.40 7.70 0.80 2.00
3 CK8 3.98 0.0019 1.40 4.50 2.70 4.40 5.30 5.70 0.95 6.80
4 CK18 4.22 0.013 1.20 10.50 4.40 2.00 4.60 8.50 1.60 0.80
5 CK18 4.00 0.037 0.70 9.60 4.20 3.00 4.60 7.70 1.70 0.48
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5.1.3  Cytokeratins in cancer 
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5.2.3 Western  blotting 
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Tumour to Normal Expression Ratios by Real Time RT PCR
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CK8 Tumour and Normal Expression Levels





















CK8 PS23 Tumour and Normal Expression Levels




















CK8 PS431 Tumour and Normal Expression Levels






















CK8 PS73 Tumour and Normal Expression Levels
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Key Name Parameter Gat
contrl cells primary ab 2.003 FL1-H G1
0.5 ug ab 2.004 FL1-H G1
1.0 ug ab 2.005 FL1-H G1
2.0 ug ab 2.006 FL1-H G1 
$
CK8 PS431 Levels in sc-120 Treated Caco2 Cells




















CK8 PS73 Levels in sc-120 Treated Caco2 Cells





















CK8 PS23 Levels in sc-120 Treated Caco2 Cells
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5.4.2  The phosphorylation of CK8 is significantly increased in tumour 


































































































































!72  " 










































 *B;   72  	   A

 +4= ! 72 
 
  %B 
 - 2; 3A?0B  95B  
  B*8
-:::4:; 	  	
















































































































































0  B80+ C ( 0   ( 0
 "(.  72$+ 0

 %?B  %?B "-.  ?0B -$   	 7  









& 		  	 














?0   ( ?
  ( ,	  	
-(0?0+7:B0!	,
24L 
 *0*+:= <8 0  










77$+ %	   0  A - 
  0
 
    =LRL 

*0*44        























  +; ( 
 2;  -.  













































































































































 "+; + +=  +:$    















,  (  .  	
 	    


















































   	 
  
+   	 














!?&  5 ( 
 













































 	  








-- . !?& ,   ( . 	  

   
 






   *0A /   














#?B =2  











































































	   	 	
























































































  ( 
 


















































































































































   
 <    	    





   .    















  	 
 !B2  , (23  	
G	  
+ 1    
















6.1.6  PP2A is a negative regulator of Wnt signalling during 
embryogenesis  
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6.2  Materials and methods 
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Tumour to Normal Expression Ratios by Real Time RT PCR


















































SET Tumour to Nornal Expression Ratios
by Real Time RT PCR According to Stage








Tumour-normal expressioin ratio of averaged











































SET Knock Down in HEK cells by Real time RT PCR

















SET Knock Down in SW480 cells by Real time RT PCR


































































































SET Expression in SW480 Cells











Beta Catenin Expression SW480 Cells
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SET Expression in HEK Cells

















Beta Catenin Expression in HEK Cells











































siRNA 1  siRNA 2  Neg. 1  Neg. 2 Unt. 1  Unt. 2
 actin 
SET 
siRNA 1  siRNA 2  Neg. 1  Neg. 2 Unt. 1  Unt. 2
 catenin 
 actin  :

6.3.4  SET siRNA treated SW480 lysates analysed using the RT
2 Profiler 
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6.4.2  SET in the Wnt signalling pathway 
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6.4.3  Hypotheses for reduced  catenin levels in the SET knock down 
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6.4.5  SET siRNA knock down and RT








































































6.4.5.1  BCL2, B cell CLL/lymphoma 2 
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6.4.5.6  V-Ets erythroblastosis virus E26 oncogene homolog 2, EST2 
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7   Final Discussion  44
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7.3 Future  Directions 
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